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Abstract.-During infection with bacteriophage 4X174, a protein, made in the presence of 30 y chloramphenicol/ml but not made in the presence of concentrations greater than 100 y/ml, has been shown to be essential for viral DNA replication. A protein with similar chromatographic properties and "chloramphenicol resistance" has now been demonstrated in cells infected with X bacteriophage.
Introduction.-Circular X DNA replicates in the presence of 30 ,tg/ml of chloramphenicol, albeit more slowly (about 1/5 the rate) than in the absence of this drug. X circular DNA is not replicated in the presence of 100 yg/ml.1 A similar situation is found with circular 4X174 replicative form (RF) which is synthesized in 30 yg/ml of chloramphenicol,2 but not in 100 jtg/ml.3' 4 In OX-infected cells a viral-specific protein required for progeny replicativeform replication is synthesized in 30 ig/ml of the drug but not in 100 ,ug/ml. This protein (coded by cistron VI of 4X174) has been isolated by chromatography on CaHPO4 columns, with the aid of a double-label technique in the presence of 30 ,ug/ml of chloramphenicol.5 The similarities between OX RF and circular X DNA replication and their differential sensitivities to the drug concentrations suggested that a X-directed protein might be detected by utilizing the same techniques successfully employed to isolate the 4X-chloramphenicolresistant protein.
Experimental.-To investigate this possibility, a 40-ml culture of E. coli CR34 (a leucine, threonine, and thymidine auxotroph) was grown to 2.3 X 108 cells/ml in minimal medium (Salivar and Sinsheimer, personal communication) with maltose (1 mg/ml) instead of glucose and 20 gg/ml each of leucine, threonine, and thymidine. The cell culture was divided so that one half was treated with 30 gg/ml of chloramphenicol for 15 min and the second half with 150 yg/ml of this drug for the same time period. The cells were then centrifuged out of suspension and each culture was resuspended in 2 ml of T-M medium (Salivar and Sinsheimer, personal communication) supplemented with 30 ug/ml chloramphenicol for those cells pretreated with that concentration of the drug or 150 ug/ml for those cells previously treated with the higher concentration. One half of each of the two 2-ml cell suspensions was then infected with xC26 (m.o.i. 5), and 3H1-leucine (25 Ae/ml) was added to the infected cultures. 14C-leucine (1 c/ml) was added to the uninfected. After 10 min at 370C all four cultures received an additional 9 ml of minimal medium (supplemented with 20 Ag/ml of threonine and 20 4g/ml of thymidine). The final concentrations of chloramphenicol, 3H-leucine, and '4C-leucine were adjusted to equal those present in the adsorption step. After 40 min at 370C the four cell cultures were collected by centrifugation. The infected and uninfected cells that were treated with 30 ug/ml of the drug were mixed, treated with lysozyme-EDTA, and lysed by freezing and thawing as described by Levine and Sinsheimer.5 An identical procedure was employed for the cells labeled in 150 pg/ml of the drug.
The two resultant lysates were dialyzed against 0.01 Al sodium phosphate buffer at pH 6.5 and chromatographed on CaHPO4 colNIumns as described elsewhere.5 The VOL. 62, 1969 BIOCHEMISTRY: LEVINE AND SINSHEIMER 1227 elution profile (CaHPO4 column) of the chloramphenicol-resistant proteins made in 30 ug/ml of this drug by the XC26-infected cells (3H-leucine) and uninfected cells (l4C-Ieucine) is shown in Figure 1 . The radioactivity in a component (or components) slightly retarded by the column was preferentially found in the infected cells (3H-leucinelabeled) as reflected in the increased ratio of 3H to 14C. The ratio of 3H to 14C in the extract before fractionation was 5.5. The variations in this ratio from fractions eluted at higher pH and ionic strengths (not shown in Fig. 1 ) were between 5.0 and 5.9. In contrast, the chromatographic profile shown in Figure 1 yielded up to a threefold increase in the 3H to 14C ratio (to 17.0). When the labels were reversed (14C for the infected cells and 3H for the uninfected cells), a similar result (reciprocal) was obtained. The increased 3H to 'IC ratio was also observed when L-lysine was employed instead of leucine as the radioactive amino acid. The portion of the chromatogram shown in Figure 1 represents approximately 3-5% of the total counts. The elution profile (second CaHPO4 column) of the chloramphenicol-resistant proteins made in 150 gg/ml of this drug by the XC26-infected and uninfected cells is shown in Figure 2 . The 3H to 14C ratio of the extract before fractionation was 4.5. The variation in the 3H to 14C ratio presented in Figure 2 is between 4.0 and 5.1. There is no indication of the chloramphenicol-resistant protein synthesized in 30 gg/ml of this drug and detected by CaHPO4 chromatography (Fig. 1) .
Two uninfected cell cultures were treated with 30 ug/ml of chloramphenicol for 15 min at 37?C. The first culture was labeled with 3H-leucine and the other with 14C-leucine as previously described. When these cells were mixed, lysed, and chromatographed on CaHPO4 columns, the drug-resistant protein found in Figure 1 was not observed. TUBE NUMBER
